Form 483

Navinta LLC Form 483, 2023-06-29

FDA issued a Form 483 to Navinta LLC on 2023-06-29 with 5 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health5 observations

Navinta LLC · Ewing, United States · Issued June 29, 2023

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Jun 2023
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Frank J Marciniak

29 Jun 2023
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Frank J Marciniak

29 Jun 2023
21 CFR 820.30(a)

Design control - no procedures

Cited by Frank J Marciniak

29 Jun 2023
21 CFR 820.50(a)

Evaluation of suppliers, contractors, etc., requirements

Cited by Frank J Marciniak

29 Jun 2023
21 CFR 820.75(a)

Lack of or inadequate process validation

Cited by Frank J Marciniak

Inspected site

NLNavinta LLCEwing, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.30(a)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere